| Financial Year |
March 31 2023 |
| Monetary Funds |
313,068,842.48 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
164,336,243.78 |
| Accounts Receivable |
585,115,746.75 |
| Advances to Suppliers |
24,795,426.56 |
| Other Receivables |
14,635,436.49 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
619,755,484.37 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
130,566,918.97 |
| Total Current Assets |
1,914,265,031.45 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
1,216,838,846.17 |
| Under-construction Projects |
93,891,762.11 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
100,020,367.45 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
20,135,593.34 |
| Deferred Income Tax Assets |
116,497,154.21 |
| Other Non-Current Assets |
41,447,499.22 |
| Sub-Total of Non-Current Assets |
1,600,829,941.82 |
| Total Assets |
3,515,094,973.27 |
| Short-Term Loans |
627,558,959.22 |
| Trading Financial liabilities |
-- |
| Notes Payable |
201,458,763.14 |
| Accounts Payable |
360,438,315.51 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
20,364,133.59 |
| Taxes Payable |
6,781,504.83 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
82,064,667.38 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
42,117,617.29 |
| Other Current Liabilities |
162,934,493.23 |
| Sub-Total of Current Liabilities |
1,517,297,659.21 |
| Long-term Loans |
349,092,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
26,228,937.88 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
409,158,832.47 |
| Total Liabilities |
1,926,456,491.68 |
| Paid-In Capital(Or Share Stock) |
398,741,458.00 |
| Capital Surplus |
673,775,430.33 |
| Surplus Reserve |
83,731,162.47 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
431,588,768.49 |
| Minority Stockholder's Interest |
812,002.89 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,587,826,478.70 |
| Owner's Equity（Stockholder's Equity） |
1,588,638,481.59 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,515,094,973.27 |
